Pelotonia for Cancer Research

A Grassroots Bike Tour With One Goal


Founded in 2008, Pelotonia was established with the objective to fund life-saving cancer research at The Ohio State University Comprehensive Cancer Center — James Cancer Hospital and Solove Research Institute. Ranked by U.S. News & World Report, Ohio State is recognized as a leader in cancer care and women's health.

As one of four major sponsors of Pelotonia, L Brands' support ensures that 100 percent of every dollar raised directly funds breakthrough ideas, treatments and cures.

In 2019, more than 7,400 Pelotonia participants representing all 50 states and 60 countries collectively raised more than $23 million for innovative cancer research. L Brands' Peloton of Riders, Virtual Riders and Volunteers was more than 3,400 strong and raised more than $8.7 million toward that effort.  To date, L Brands has donated more than $64 million for Pelotonia, an organization that has contributed approximately $207 million directly to cancer research through its first 11 rides.

By getting involved with Pelotonia, L Brands is able to give back in a way that can ultimately benefit our global community by helping to end to cancer as we know it. As long as even one person is fighting cancer ... WE KEEP GOING.

About The Ohio State University Comprehensive Cancer Center — James Cancer Hospital and Solove Research Institute:  The James contributes to the global war on cancer by conducting scientific research that translates to leading-edge cancer diagnostics, treatments and prevention strategies. Leveraging the university’s academic depth and breadth, the OSUCCC – James’ nearly 300 researchers and approximately 200 subspecialized oncologists are speeding the discovery and delivery of molecular-based therapies for individual cancers, leading to more options, faster responses, fewer side effects and better outcomes for patients.

In December 2014, after a decade of planning, design and construction, the OSUCCC – James opened a 21-story, 1.1-million-square-foot cancer hospital to replace the original James that had opened in 1990. The new 356-bed cancer hospital brings researchers and clinicians into closer working proximity, facilitating translational research and giving patients quicker access to innovative science-based treatments that target their individual cancer. No cancer is routine, and the OSUCCC – James is not a routine cancer hospital. It is a transformational facility that stands as a model for all 21st century cancer hospitals by bringing personalized clinical care, research and education together in a subspecialized model that furthers the institution’s pursuit of a cancer-free world.